Internal Server Error

About Starfish Ventures

Starfish Ventures is a venture capital firm founded in 2001. It is primarily based out of Melbourne, Australia. As of Aug 2023, Starfish Ventures has invested in 42 companies. It primarily invests in Series A round in Australia based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to High Tech and Consumer. Most recently it participated in the $***** Seed round of DIAL4242 Overall, Starfish Ventures portfolio has seen 6 IPOs and 16 acquisitions including key companies like Protagonist Therapeutics, Nitro and iSelect. A lot of funds co-invest with Starfish Ventures, with names like Lilly Ventures sharing a substantial percentage of its portfolio. Starfish Ventures has team of 5 people including 2 partners.
Key Metrics
Portfolio Locations
Rounds of Entry
Series A, Seed & 3 more
Portfolio Acquisitions
Portfolio Soonicorns

Starfish Ventures' List of Top Investments

Starfish Ventures has a portfolio of 42 companies. Their most notable investments are in DesignCrowd and DesignCrowd.Their portfolio spans across Australia, United States, India and 2 more locations. They have invested in Enterprise Applications, High Tech, Consumer and 23 other sectors, across stages such as Series A, Seed  and 3 more. Here is the list of top investments by Starfish Ventures:
Developer of oral peptide therapeutics for gastrointestinal diseases. It offers orally stable peptide therapeutics for drugs against inflammatory bowel diseases (IBD), irritable bowel syndrome disease-related targets, and gastrointestinal diseases and disorders. It offers IL-6, a peptide antagonist as an anti-inflammatory agent; and a novel hepcidin peptide mimetic for the treatment of iron overload related disorders. Its pipeline includes PTG-100, an a4ß7 integrin-specific oral peptide antagonist for the treatment of IBDs; and IL-23, a receptor oral peptide antagonist for the treatment of IBDs.

Key facts about Protagonist Therapeutics

Provider of AI-powered solutions for healthcare provider engagement in life sciences. The company offers tools for strategy orchestration, automated intelligence, and amplified engagement. These solutions support brand, commercial, medical affairs, and medtech teams. The platform uses contextual intelligence, omnichannel data interface, and agentic AI to provide insights and recommendations.

Key facts about Aktana

Cloud-based digital transaction management suite solutions. It allows users to create, prepare, and edit PDF documents while collaborating with the team. It also provides users with a software solution that enables users to create, merge, edit, convert, and review PDF files. It also provides secure and legally binding e-signature solutions. It is the tool available on a subscription-based pricing model.

Key facts about Nitro

iSelect is an online aggregator of financial products. Offers comparison services for health and life insurance, car insurance, home insurance, travel insurance, credit cards and home loans. Users enter the required details on the platform and an advisor contacts for providing assistance. The advisor helps the users to choose from the multiple products provided by service providers. Also provides the comparison of utility services including electricity, gas, broadband and mobile phone plans.

Key facts about iSelect

Audinate is a digital audio networking technology provider. Its Dante platform distributes digital audio signals over computer networks and is designed to connect IT networking to the professional AV industry. Its patented Dante media networking technology has been adopted by various manufacturers and professionals in the audio/visual industry. It is used for broadcast, live performance, recording and production events, commercial installation, and communications systems.

Key facts about Audinate

  • Founded Year: 2006
  • Location: Sydney (Australia)
  • Annual Revenue: £4.66M as on Jun 30, 2024
  • Stage: Public
  • Total Funding till date: $7.39M
  • Employee Count: 161 as on Jul 01, 2024
  • Investors: Herald Investment Management, UBS and 4 Others
  • Latest Funding Round: Post IPO, Sep 08, 2023, $*****
  • Highlight: Public

Starfish Ventures' Investments by Stage

Starfish Ventures has made 21 investments in Series A stage with an average round size of $4.26M, 11 investments in Seed stage with an average round size of $732K, 3 investments in Series B stage with an average round size of $6M, 3 investments in Series C stage with an average round size of $36.6M and 1 investment in Post IPO stage.
Here are Starfish Ventures' investments by stage:
Stage of entry
No. of Investments
Series A
21
Seed
11
Series B
3
Series C
3
Post IPO
1
Breakdown of Starfish Ventures' investments by stage of entrySeries A (21)Seed (11)
Note: We have considered here, only first round of investments

Starfish Ventures' Investments by Sector

Starfish Ventures has a diverse portfolio, with companies operating in the Enterprise Applications, High Tech, Life Sciences, Consumer and HealthTech. Notably, it has invested in 32 Tech companies, 27 Enterprise (B2B) companies, 18 Software companies and at least 12 companies focusing on Consumer (B2C).
Here are Starfish Ventures' investments by sector:
Sector
No. of Investments
Enterprise Applications
14
High Tech
6
Life Sciences
6
Consumer
4
HealthTech
4
Others
40
Breakdown of Starfish Ventures' investments by sectorsEnterprise Applic... (14)High Tech (6)
Note: We have considered here, only first round of investments

Starfish Ventures' Investments by Geography

Starfish Ventures has made most investments in Australia (20), followed by United States where it has made 16 investments.
Here are Starfish Ventures' investments by geography:
Country
No. of Investments
Australia
20
United States
16
India
1
Netherlands
1
United Kingdom
1
Breakdown of Starfish Ventures' investments by countriesAustralia (20)United States (16)
Note: We have considered here, only first round of investments

Starfish Ventures' recent investments

Starfish Ventures has not made any investment in 2026 so far.
Here are the most recent investments by Starfish Ventures:
Date
Company
Location
Round Details
Round Amount
Co-Investors
Aug 21, 2023
India
Seed
6069
Aug 20, 2021
Australia
Seed
3388
Feb 01, 2021
Australia
Series C
7625
  [+5]
Jun 08, 2016
United States
Series B
1683
Jul 24, 2015
United States
Series C
4098
  [+6]

IPOs and Publicly Listed companies in Starfish Ventures' Portfolio

6 of Starfish Ventures' portfolio companies have become public. Audinate got listed on the Australian Securities Exchange (ASX), in Jun 2017 at marketcap of $52.1M and Protagonist Therapeutics got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ) at marketcap of $196M.
Here are Starfish Ventures' portfolio companies that went public:
Company
IPO Date
First Invested on
First Round of Investment
Round Size
Jun 30, 2017
Apr 17, 2008
Series A
7528
Aug 11, 2016
Sep 19, 2006
Series A
9273
Dec 11, 2013
Apr 2008
Seed
1364
Jun 24, 2013
-
-
7853
Oct 24, 2007
Aug 08, 2006
Series A
1931

Acquired companies in Starfish Ventures' Portfolio

16 companies from Starfish Ventures' portfolio have been acquired. The most recent acquisition was Echoview in Sep 2025 by Zunibal for $*****.
Here are Starfish Ventures' portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
Sep 03, 2025
Nov 2007
Series A
5828
Jan 30, 2024
Nov 20, 2012
Series A
6258
Nov 15, 2022
Apr 03, 2012
Series A
2094
Oct 07, 2021
Oct 25, 2010
Series B
4092
Nov 09, 2018
Sep 2005
Post IPO
1381

Team profile of Starfish Ventures

Starfish Ventures has a team of 5 members including 2 Partners and 2 Principals located in Australia, Thailand and 1 more location. Starfish Ventures' team sits on the board of 1 company.
Here is a list of all team members in Starfish Ventures:
Name
Designation
Location
Board Memberships
Contact Details
Partner
Melbourne
Partner
Melbourne
-
Principal
Hoffman Estates
-
-
Principal
Thailand
-
-

Co-investors of Starfish Ventures

Over the past 22 years, 119 investors have co-invested in Starfish Ventures's portfolio companies. This includes funds and angels.

  • Invested before Starfish VenturesStartmate, Government of Australia and 28 others have invested in rounds before Starfish Ventures. There are 2 companies where Startmate has invested before Starfish Ventures and 1 company where Government of Australia has invested before Starfish Ventures.
  • Top Co-investors of Starfish Ventures39 investors entered a company along with Starfish Ventures. These include investors like Lilly Ventures (1 company).
  • Invested after Starfish VenturesA total of 50 investors have invested in Starfish Ventures's portfolio after their investments. Top Investors include Regal Funds Management (2 companies), Alium Capital (2 companies) and Canaan (1 company).

Recent News related to Starfish Ventures

View all news related to Starfish Ventures

FAQs about Starfish Ventures

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford